January 21, 2026 by Mohr Marketing
Bard Settlement vs. Covidien Growth: Where to Put Your Budget in 2026 For the last five years, MDL 2846 (In re: Davol, Inc./C.R. Bard, Inc.) has been a cornerstone of many mass tort inventories. However, following Becton Dickinsonβs October 2024 announcement of a global settlement framework (approx. $1.9 billion reserved for ~38,000 claims), the strategy…
Continue reading The Bard Hernia Mesh Landscape in 2026
January 21, 2026 by Mohr Marketing
Mohr Marketing Launches “Post-Settlement” Protocol for Bard Mesh; Opens New Acquisition Channels for Emerging Covidien Litigation Dual-strategy for 2026: Strict “Tier 1” filtration for mature Bard dockets and aggressive growth focus for Covidien (MDL 3029). Mohr Marketing, a specialized digital agency for the legal sector, today announced a strategic overhaul of its hernia mesh acquisition…
Continue reading The “Hernia Mesh” bucket is no longer a single asset class
January 21, 2026 by Mohr Marketing
Mohr Marketing Launches “Post-Settlement” Intake Protocol to Navigate Stricter 2026 Bard Hernia Mesh Docket Control Mohr Marketing, a specialized digital agency for the legal sector, today announced the launch of its “Tier 1” Bard Intake Protocol, a proprietary acquisition program designed specifically for the post-settlement administration phase of the C.R. Bard Hernia Mesh litigation (MDL…
Continue reading Intake Protocol to Navigate Stricter 2026 Bard Hernia Mesh Docket
February 10, 2025 by Mohr Marketing
Introduction To Hernia Mesh: Overview And Recent Developments A hernia occurs when an internal organ or tissue protrudes through a weak spot in the surrounding muscle or connective tissue. To address this condition, surgical procedures often involve the use of hernia mesh, a medical device designed to reinforce weakened areas and provide additional support. Hernia…
Continue reading Litigation And Legal Cases: Recent Trends And Resolutions